In the case of the human Q39H carriers, we suggest that LYNX2 protein is expressed but does not have the binding, and in turn inhibitory capability, of wild-type LYNX2, the consequence of which is nAChR hypersensitivity and elevated anxiety levels. This evidence concerns the gene CHRNA4 and Anxiety.